androgen receptor inhibitor therapy
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for androgen receptor inhibitor therapy, covering 2024-03-19 to 2024-03-19. Get the full timeline:
Most recent: Clinical Trial Update: A Salvage Trial of AR Inhibition With ADT and Apalutamide With Radiation Therapy Followed by Docetaxel in Men With PSA Recurrent Prostate Cancer After Radical Prostatectomy (STARTAR) [Phase 2]